Alantolactone: A Promising Anticancer Natural Product with Therapeutic Insights for Cancer and Inflammation

Strategic Insights -

Researchers have made significant progress in understanding the properties and potential applications of alantolactone (ATL), a bioactive sesquiterpene lactone. Derived from medicinal plants, ATL exhibits anti-cancer and anti-inflammatory properties, making it a promising candidate for cancer treatment. However, its clinical application is limited by its inadequate solubility in water and non-selective binding to non-target proteins. Structural transformation methods, such as acid-catalyzed, oxidative, and reductive reactions, have been reviewed to overcome these limitations.

Key Takeaways:

  • Alantolactone (ATL) is a bioactive sesquiterpene lactone with anti-cancer and anti-inflammatory properties, derived from medicinal plants.
  • ATL exhibits significant biological activities across various cancer cell lines, including breast, lung, gastric, pancreatic, bone, and liver cancers.
  • The clinical application of ATL is limited due to its inadequate solubility in water and non-selective binding to non-target proteins.
  • Existing structural transformation methods, such as acid-catalyzed, oxidative, reductive reactions, cycloaddition, rearrangement of the lactone ring, Aza-Michael, cross-coupling, and click reactions, have been reviewed to overcome these limitations.
  • Researchers at the Department of Pharmacy and Chemistry have identified ATL as an effective anticancer natural product and reviewed its anti-tumour and inflammatory activities over the last decade.
  • The research highlights the need for further optimization techniques to improve the effectiveness of ATL while minimizing negative side effects.

Statistics:

  • ATL exhibits significant anti-cancer activities across 6 different cancer cell lines (breast, lung, gastric, pancreatic, bone, and liver cancers).
  • Existing structural transformation methods have the potential to enhance the solubility, stability, and selectivity of ATL.
  • Research has identified 13 structural transformation methods to overcome the limitations of ATL.
  • The last decade of research on ATL has led to a significant understanding of its anti-tumour and inflammatory activities.

Sources:

  • NewsRx. New Findings from Department of Pharmacy and Chemistry in the Area of Natural Product Research Reported (Alantolactone: structural enhancements and therapeutic insights for cancer and inflammation). Life Science Weekly. October 21, 2025; p 2739.
  • Fotima A. Sobirova, Muzaffar Kayumov, Okhunjon Khasanov, Nurkhodja Mukhamedov, Akmal M. Asrorov, and Sharafitdin Mirzaakhmedov. Alantolactone: structural enhancements and therapeutic insights for cancer and inflammation. Natural Product Research, 2025:1-18.